Hypertension treatment company Kona Medical wins backing of unnamed medical technology company as well as venture firms including Essex Woodlands and Morgenthaler Ventures.

Heritage Group secures $157m fund with widespread strategic backing in the healthcare sector.

The Japan-based pharmaceuticals company transfers an irritable bowel syndrome drug to Drais and invests $13m with venture firms, in a similar deal to one hatched by Astellas two months ago.

The US-based crowd-sourcing platform backed by pharmaceutical group Eli Lilly raises $5.1m of a planned $7.5m round.

The company is planning to build into a network of four or five labs including New York, news provider Xconomy said.

The Swiss-based healthcare company backs the US-based medical device company's series D alongside venture firms including Abingworth and the CIA's In-Q-Tel.

Eli Lilly is joined investing in TVM's seventh life sciences fund by fund of funds Teralys Capital, which invested $65m.

Agendia was founded in 2003 as a spin-off of the Netherlands Cancer Institute (NKI)/Antoni van Leeuwenhoek Hospital in Amsterdam where it had access to the world's largest frozen tumour bank.

The syndicate was joined by several new international investors including Debiopharm and Korys, the Colruyt's family office, and existing investors, including venture capital firm Gilde Healthcare Partners, family office Van Herk Group, Dutch bank ING Corporate Investments and Breedinvest, the holding company of the Blokker households goods stores.